Form 424B5 Atara Biotherapeutics Inc For: 16 March
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Inc stock price live, this page displays NASDAQ ATRA stock exchange data. View the ATRA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Atara Biotherapeutics Inc real time stock price chart below.
What Is the Atara Biotherapeutics Inc Stock Price Today?
The Atara Biotherapeutics Inc stock price today is 5.3300.
What Is the Stock Symbol for Atara Biotherapeutics Inc?
The stock ticker symbol for Atara Biotherapeutics Inc is ATRA.
Is ATRA the Same as $ATRA?
$ATRA is a common way to refer to the Atara Biotherapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Atara Biotherapeutics Inc Trade On?
Atara Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Atara Biotherapeutics Inc a Good Stock to Buy?
Determining whether Atara Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Atara Biotherapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATRA quote. (ISIN: US0465132068)
What Is the Atara Biotherapeutics Inc Stock Price Today?
The Atara Biotherapeutics Inc stock price today is 5.3300.
What Is the Stock Symbol for Atara Biotherapeutics Inc?
The stock ticker symbol for Atara Biotherapeutics Inc is ATRA.
Is ATRA the Same as $ATRA?
$ATRA is a common way to refer to the Atara Biotherapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Atara Biotherapeutics Inc Trade On?
Atara Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Atara Biotherapeutics Inc a Good Stock to Buy?
Determining whether Atara Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Atara Biotherapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATRA quote. (ISIN: US0465132068)
NASDAQ
Currency in USD
5.3200
+0.1700(+3.30%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.1100
5.3550
52 wk Range
3.9200
19.1450
ATRA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.11005.3550
52 wk Range
3.920019.1450
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATRA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
9.3333
Upside
+75.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 8K Atara Biotherapeutics Inc For: 12 March
- Investing.com
- Form 424B5 Atara Biotherapeutics Inc For: 16 March
- Investing.com
- Form 8K Atara Biotherapeutics Inc For: 12 March
- Investing.com
- Form 8K Atara Biotherapeutics Inc For: 3 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Compare ATRA to Peers and Sector
Metrics to compare | ATRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATRAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 1.3x | −3.4x | −0.5x | |
PEG Ratio | 0.01 | −0.09 | 0.00 | |
Price / Book | −1.1x | 2.3x | 2.6x | |
Price / LTM Sales | 0.4x | 25.8x | 3.2x | |
Upside (Analyst Target) | 15.4% | 226.8% | 47.6% | |
Fair Value Upside | Unlock | 6.8% | 6.1% | Unlock |
Analyst Ratings
1 Buy
1 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 9.3333
(+75.44% Upside)
Earnings
Latest Release
Mar 16, 2026
EPS / Forecast
-0.25 / -0.25
Revenue / Forecast
1.6M / --
People Also Watch
FAQ
What Is the Atara Biotherapeutics Inc (ATRA) Stock Price Today?
The Atara Biotherapeutics Inc stock price today is 5.3200 USD.
What Stock Exchange Does Atara Biotherapeutics Inc Trade On?
Atara Biotherapeutics Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Atara Biotherapeutics Inc?
The stock symbol for Atara Biotherapeutics Inc is "ATRA."
What Is the Atara Biotherapeutics Inc Market Cap?
As of today, Atara Biotherapeutics Inc market cap is 43.6700M USD.
What Is Atara Biotherapeutics Inc's Earnings Per Share (TTM)?
The Atara Biotherapeutics Inc EPS (TTM) is 2.5700.
From a Technical Analysis Perspective, Is ATRA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Atara Biotherapeutics Inc Stock Split?
Atara Biotherapeutics Inc has split 1 times.
How Many Employees Does Atara Biotherapeutics Inc Have?
Atara Biotherapeutics Inc has 14 employees.
What is the current trading status of Atara Biotherapeutics Inc (ATRA)?
As of Apr 15, 2026, Atara Biotherapeutics Inc (ATRA) is trading at a price of 5.3200 USD, with a previous close of 5.1500 USD. The stock has fluctuated within a day range of 5.1100 USD to 5.3550 USD, while its 52-week range spans from 3.9200 USD to 19.1450 USD.
What Is Atara Biotherapeutics Inc (ATRA) Price Target According to Analysts?
The average 12-month price target for Atara Biotherapeutics Inc is 9.3333 USD, with a high estimate of 18 USD and a low estimate of 4 USD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +75.44% Upside potential.
What Is the ATRA Premarket Price?
ATRA's last pre-market stock price is 5.1100 USD. The pre-market share volume is 190.0000, and the stock has decreased by -0.0400, or -0.7800%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.